assay shows value for patients with low-risk prostate cancer
Published 4 years ago • 190 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
34:43
prostate cancer: evaluation and management of low risk disease
-
50:02
active surveillance for favourable risk prostate cancer
-
35:21
(10) active surveillance for low-risk prostate cancer (cap)
-
50:38
the impact of a genomic assay on urologist treatment preference in active surveillance-eligible men
-
27:03
segment 2: risk assessment in prostate cancer
-
46:19
webinar - beyond psa: the exodx prostate™ test (epi) as a precision genomic biomarker
-
4:00
active surveillance criteria for watching low risk prostate cancer
-
25:24
active surveillance in 2021 part 2: imaging and biomarkers
-
11:13
active surveillance in favorable intermediate-risk prostate cancer
-
5:02
predict-rt study for patients with high-risk prostate cancer
-
20:04
the exodx™ prostate test: prostate cancer and implications for value based care part 1
-
9:27
role of mr-targeted prostate biopsy in active surveillance
-
47:03
what's new in active surveillance for prostate cancer
-
19:22
prostate cancer genetic testing: how to hedge bets in selecting patients for surveillance
-
1:43
making treatment and screening decisions for patients with prostate cancer
-
16:51
hifu for prostate cancer in asia
-
21:23
low-risk prostate cancer treatment - musc hollings
-
20:48
mri in the enhanced detection of prostate cancer: what urologists need to know
-
34:34
active surveillance of prostate cancer with yushen qian, md